U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891208) titled 'Nasal High Flow Oxygen in Patients With Lower-Limb Ischaemia' on Oct. 16.

Brief Summary: A prospective, single arm pilot efficacy study designed to evaluate the physiological and symptomatic effects of normobaric Nasal High Flow (NHF) oxygen therapy in patients with lower limb ischaemia experiencing rest pain and/or wound related pain.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Nasal High Flow Oxygen Therapy Effect on Lower Limb Ischaemia

Intervention: DEVICE: Nasal high flow oxygen

Normobaric nasal high flow oxygen for lower limb ischaemia

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fisher and P...